Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide

Figure 2

Appearance and progression of secondary tumor. T₂-weighted ((a) and (c)) and gadolinium enhanced T₁-weighted ((b) and (d)) images demonstrating the first appearance of the secondary tumor. ((e)–(h)) Gadolinium enhanced T₁-weighted images showing progression of secondary tumor.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)